Stay updated on Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page
- Check5 days agoChange DetectedThe history now shows a new revision entry, v3.6.3, replacing the previous v3.6.2. This signals that the study record has been updated since the last version.SummaryDifference0.1%

- Check12 days agoChange DetectedThe study history shows a new revision entry labeled v3.6.2, replacing the previous v3.6.0, indicating an update to the page's version.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe record now shows that recruitment has ended, and the history reflects a new revision (v3.6.0) replacing the previous version (v3.5.5).SummaryDifference0.2%

- Check33 days agoChange DetectedThe history now includes a new revision entry labeled v3.5.5, replacing the earlier v3.5.4. This reflects a minor site revision reflected in the record history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page history now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This marks a new version of the page record on ClinicalTrials.gov.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page revision/build number was updated (v3.5.2 → v3.5.3), reflecting a site/version change rather than a change to the clinical trial record details.SummaryDifference0.1%

Stay in the know with updates to Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.